Changes in serum levels of type I and III procollagen extension peptides during infusion of human parathyroid hormone fragment (1–34)

Parathyroid hormone (PTH) inhibits collagen synthesis in vitro, in organ or cell culture and cell‐free translation systems. We have designed studies to measure the effects of PTH on collagen synthesis in vivo in humans, utilizing measurements of the serum levels of procollagen extension peptides during and after infusion of synthetic human PTH (hPTH) fragment (1–34). Radioimmunoassays for the carboxy‐terminal peptide of type I procollagen (pColl‐C) and the amino‐terminal peptide of type III procollagen (pColl‐III‐N) were used to measure acute changes in serum during and after hPTH(1–34). In all six osteoporotic subjects and two normal individuals, serum levels of pColl‐I‐C were decreased by 16 hr of infusion and returned towards normal 14 hr after the infusion was discontinued; serum levels of pColl‐III‐N did not change significantly during the infusion, but were increased at 14 hr after the infusion was discontinued. The PTH‐induced decrease in levels of pColl‐I‐C correlated with an increase in blood levels of ionized calcium. In all but two subjects the serum levels of 1,25‐dihydroxy vitamin D [1,25(OH)2D] were also increased during the period when serum levels of pColl‐I‐C were decreased. These results are compatible with the conclusion that infusion of PTH acutely inhibits type I (bone) collagen synthesis, but not type III collagen synthesis. These effects could be direct or indirect, related in part to PTH‐induced increased 1‐α‐hydroxylation of 25‐(OH) vitamin D and the resultant increased serum levels of 1,25(OH)2D.